Application no. and date | 18753208.0 (espacenet) (Federated) (European Patent Register), 20180820 | Patent/reg. no. and date | DK/EP 3672951, 20230830 | Publication date | 20200701 | Priority no. and date | EP 17187100, 20170821 | EP pub. no. and date |
EP 3672951 20200701 | Effective date | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | Applicant ref. no. | P83020DK01 | Inventor | SCHIEMANN, Kai, Am Roedergraben 8
64342 Seeheim-Jugenheim, DE, TANZER, Eva-Maria, 5 Riverhurst Road Apt. 642
Billerica, MA 01821, US, KLEIN, Markus, Lindenweg 35
64291 Darmstadt, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/498 (2006.01) , A61P 31/00 (2006.01) , A61P 35/00 (2006.01) , C07D 241/44 (2006.01) , C07D 403/04 (2006.01) , C07D 403/12 (2006.01) , C07D 403/14 (2006.01) , C07D 405/04 (2006.01) , C07D 413/14 (2006.01) , C07D 417/14 (2006.01) , C07D 471/04 (2006.01) , C07D 495/10 (2006.01) | Title | QUINOXALINDERIVATER SOM ADENOSINRECEPTORANTAGONISTER | Int. application no. | EP2018072397 | Int. publication no. | WO2019038214 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|